Naftopidil has been investigated for the treatment of Disorder of Urinary Stent. It is grouped under the following drug class(es): Alpha-1 Blockers. Its therapeutic use is listed as urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Flivas, Naftopidilum and 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol. Its PubChem CID is 4418.
Naftopidil
| CAS No | 57149-07-2 |
|---|---|
| Molecular Formula | C24H28N2O3 |
| Molecular Weight | 392.5 g/mol |
| Synonyms | 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Naftopidil has been investigated for the treatment of Disorder of Urinary Stent. It is grouped under the following drug class(es): Alpha-1 Blockers. Its therapeutic use is listed as urological agents.
The listed CAS number is 57149-07-2.
The listed molecular formula is C24H28N2O3.
The listed molecular weight is 392.5 g/mol.
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol.
The source lists Flivas, Naftopidilum and 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol.